RE: Rns...27 Jan 2022 07:54
The is the company making part
Of significance, QMENTA recently obtained FDA 510(k) clearance for their platform, and we anticipate another partner to receive FDA 510(k) clearance for their platform in early '22. FDA market clearance ALLOWS COMMERCIALIATION to commence in the USA. This is the pinnacle milestone for being able to sell medical devices without restriction, and companies must demonstrate compliance with federal quality regulations in the design and development of each device. In addition, a major pharmaceutical company is working with yet another partner to develop their own custom platform which includes 3rd party artificial intelligence (AI) solutions. This company was very selective in choosing which 3rd party applications would participate in early launch activity in the USA and in Europe. IB software was one of the few selected partners given our unique and proven capabilities. This is highly encouraging as we expect an accelerated penetration of our solution in the global medical imaging market with the backing and broad outreach of a multibillion-dollar organization.
An excellent very detailed letter